Rodrigues F, Jasielec J, Perpich M, Kim A, Moma L, Li Y
iScience. 2025; 28(1):111620.
PMID: 39845416
PMC: 11750583.
DOI: 10.1016/j.isci.2024.111620.
Ramanagoudr-Bhojappa R, Tryon R, Lach F, Donovan F, Maxwell R, Rosenberg A
Blood Adv. 2024; 8(4):899-908.
PMID: 38191666
PMC: 10875269.
DOI: 10.1182/bloodadvances.2023011888.
Zoller J, Trajanova D, Feurstein S
Front Oncol. 2023; 13:1205855.
PMID: 37904876
PMC: 10613526.
DOI: 10.3389/fonc.2023.1205855.
Zerella J, Homan C, Arts P, Brown A, Scott H, Hahn C
Front Oncol. 2023; 13:1183318.
PMID: 37377909
PMC: 10291195.
DOI: 10.3389/fonc.2023.1183318.
Molteni E, Bono E, Galli A, Elena C, Ferrari J, Fiorelli N
Blood. 2023; 142(7):643-657.
PMID: 37216690
PMC: 10644067.
DOI: 10.1182/blood.2022019304.
C.845G>A: Pathogenic Variant in Patient with Dyskeratosis Congenita.
Kocheva S, Gjorgjievska M, Martinova K, Antevska-Trajkova Z, Jovanovska A, Plaseska-Karanfilska D
Balkan J Med Genet. 2022; 24(2):89-93.
PMID: 36249522
PMC: 9524180.
DOI: 10.2478/bjmg-2021-0027.
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.
Saygin C, Roloff G, Hahn C, Chhetri R, Gill S, Elmariah H
Blood Adv. 2022; 7(4):549-554.
PMID: 36001442
PMC: 9979761.
DOI: 10.1182/bloodadvances.2022008172.
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages.
Feurstein S, Trottier A, Estrada-Merly N, Pozsgai M, McNeely K, Drazer M
Blood. 2022; 140(24):2533-2548.
PMID: 35969835
PMC: 9918848.
DOI: 10.1182/blood.2022015790.
Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders.
DeRoin L, de Andrade Silva M, Petras K, Arndt K, Phillips N, Wanjari P
Hum Mutat. 2022; 43(7):950-962.
PMID: 35419889
PMC: 9177640.
DOI: 10.1002/humu.24374.
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Yang F, Long N, Anekpuritanang T, Bottomly D, Savage J, Lee T
Blood. 2021; 139(8):1208-1221.
PMID: 34482403
PMC: 9211447.
DOI: 10.1182/blood.2021011354.
GATA2 deficiency syndrome: A decade of discovery.
Homan C, Venugopal P, Arts P, Shahrin N, Feurstein S, Rawlings L
Hum Mutat. 2021; 42(11):1399-1421.
PMID: 34387894
PMC: 9291163.
DOI: 10.1002/humu.24271.
Incidental findings from cancer next generation sequencing panels.
Maani N, Panabaker K, McCuaig J, Buckley K, Semotiuk K, Farncombe K
NPJ Genom Med. 2021; 6(1):63.
PMID: 34282142
PMC: 8289933.
DOI: 10.1038/s41525-021-00224-6.
Unique ethnic features of mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia.
Choi E, Cho Y, Hur E, Jang S, Kim N, Park H
Haematologica. 2021; 107(2):510-518.
PMID: 33626862
PMC: 8804579.
DOI: 10.3324/haematol.2020.270553.
Next-Generation Sequencing of in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations.
Bannon S, Routbort M, Montalban-Bravo G, Mehta R, Jelloul F, Takahashi K
Front Oncol. 2021; 10:582213.
PMID: 33585199
PMC: 7878971.
DOI: 10.3389/fonc.2020.582213.
Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Andres-Zayas C, Suarez-Gonzalez J, Rodriguez-Macias G, Dorado N, Osorio S, Font P
Mol Oncol. 2021; 15(9):2273-2284.
PMID: 33533142
PMC: 8410541.
DOI: 10.1002/1878-0261.12921.
Germline variants drive myelodysplastic syndrome in young adults.
Feurstein S, Churpek J, Walsh T, Keel S, Hakkarainen M, Schroeder T
Leukemia. 2021; 35(8):2439-2444.
PMID: 33510405
PMC: 8725861.
DOI: 10.1038/s41375-021-01137-0.
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations.
Feurstein S, Adegunsoye A, Mojsilovic D, Vij R, West DePersia A, Rajagopal P
Blood Adv. 2020; 4(19):4873-4886.
PMID: 33035329
PMC: 7556157.
DOI: 10.1182/bloodadvances.2020001721.
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).
Brown A, Hahn C, Scott H
Blood. 2020; 136(1):24-35.
PMID: 32430494
PMC: 7332898.
DOI: 10.1182/blood.2019000937.
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.
Brown A, Arts P, Carmichael C, Babic M, Dobbins J, Chong C
Blood Adv. 2020; 4(6):1131-1144.
PMID: 32208489
PMC: 7094007.
DOI: 10.1182/bloodadvances.2019000901.
Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
Schratz K, DeZern A
Hematol Oncol Clin North Am. 2020; 34(2):333-356.
PMID: 32089214
PMC: 7875473.
DOI: 10.1016/j.hoc.2019.10.002.